Published in Neurol Clin on March 15, 2013
Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin (2013) 0.80
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients. Neurology (1961) 3.72
Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40
Diabetic muscle infarction: an underdiagnosed complication of long-standing diabetes. Diabetes Care (2003) 3.02
Diabetic amyotrophy. Br Med J (1955) 2.24
Treatment and outcomes of diabetic muscle infarction. J Clin Rheumatol (2005) 2.10
Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol (1995) 2.09
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Muscle infarction in patients with diabetes mellitus: MR imaging findings. Radiology (1999) 1.92
Diabetic ophthalmoplegia; report of case, with postmortem study and comments on vascular supply of human oculomotor nerve. AMA Arch Neurol Psychiatry (1957) 1.91
Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve (1996) 1.69
Abdominal pain caused by diabetic radiculopathy. Ann Intern Med (1977) 1.63
Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology (1999) 1.61
The reflex sympathetic dystrophy syndrome (RSDS). III. Scintigraphic studies, further evidence for the therapeutic efficacy of systemic corticosteroids, and proposed diagnostic criteria. Am J Med (1981) 1.57
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
The natural history of diabetic femoral neuropathy. Q J Med (1991) 1.49
Electrodiagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy. Clin Neurophysiol (2011) 1.47
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Femoral neuropathy. Neurology (1960) 1.29
Focal infarction of muscle in diabetics. Diabetes Care (1987) 1.27
Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol (1994) 1.22
Lumbosacral plexus neuropathy. Neurology (1981) 1.19
Diabetic thoracoabdominal neuropathy: clinical and electrodiagnostic features. Ann Neurol (1981) 1.19
Bell's palsy and diabetes mellitus. Lancet (1971) 1.15
Pathology of oculomotor nerve palsy in diabetics. Neurology (1970) 1.14
Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology (2009) 1.14
Diabetic thoracic polyradiculopathy presenting as abdominal swelling. Br Med J (Clin Res Ed) (1984) 1.12
Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy. Clin Neurophysiol (1999) 1.09
Diabetic truncal neuropathy: topography of the sensory deficit. Ann Neurol (1989) 1.07
Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings. Ann Neurol (1982) 1.07
Meralgia paresthetica: relation to obesity, advanced age, and diabetes mellitus. Neurology (2011) 1.04
Upper extremity diabetic muscle infarction in three patients with end-stage renal disease: a case series and review. J Clin Rheumatol (2009) 1.03
Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci (1996) 1.02
Proximal diabetic neuropathy. Ann Neurol (1977) 0.99
Diabetic truncal polyneuropathy. Arch Neurol (1981) 0.97
Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Ann Neurol (1984) 0.95
Diabetic truncal neuropathy presenting as abdominal hernia. Neurology (1989) 0.94
Subacute diabetic proximal neuropathy. Mayo Clin Proc (1997) 0.93
The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol (1991) 0.93
High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology (1994) 0.92
Subacute proximal diabetic neuropathy. Neurology (1976) 0.91
Lumbosacral plexus neuritis. Neurology (1981) 0.91
Diabetic amyotrophy. Am J Med (1963) 0.90
Infarction of thigh muscle in the diabetic patient. Neurology (1973) 0.90
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1997. A 54-year-old diabetic woman with pain and swelling of the leg. N Engl J Med (1997) 0.90
Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. Mayo Clin Proc (1981) 0.89
Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci (1982) 0.89
The prevalence of diabetes mellitus in patients with Bell's palsy. Acta Neurol Scand (1972) 0.87
Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve (2001) 0.86
Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol (1997) 0.85
Proximal diabetic neuropathy presenting with respiratory weakness. J Neurol Neurosurg Psychiatry (1999) 0.85
The syndrome of diabetic amyotrophy. Ann Neurol (1977) 0.85
Diabetic Lumbosacral Polyradiculoneuropathies. Curr Treat Options Neurol (2001) 0.83
Diabetic neuropathy, the great masquerader: truncal neuropathy manifesting as abdominal pseudohernia. Endocr Pract (2006) 0.83
Diabetic thoracic radiculopathy: electrodiagnostic study. Muscle Nerve (1986) 0.83
Case-of-the-month: painful thigh mass in a young woman: diabetic muscle infarction. Muscle Nerve (1992) 0.82
Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med (2009) 0.81
Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies. J Endocrinol Invest (2011) 0.81
Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev (2012) 0.80
Cranial nerve lesion in diabetic patients. Coll Antropol (2011) 0.79
Bilateral diabetic thigh muscle infarction. J Neuroimaging (1994) 0.79
Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol (1992) 0.79
Diabetic muscle infarction. Emerg Med J (2007) 0.78
Treatable lumbosacral polyradiculitis masquerading as diabetic amyotrophy. J Neurol Sci (1997) 0.76
Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy. Acta Neurol Scand (2003) 0.76
AAEE case report #13: diabetic amyotrophy. Muscle Nerve (1987) 0.76
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol (2007) 5.46
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum (2013) 3.55
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol (2005) 3.07
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (2008) 2.95
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler (2008) 2.28
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial. JAMA Neurol (2013) 1.90
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol (2010) 1.81
Primary lateral sclerosis. Muscle Nerve (2007) 1.52
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA (2012) 1.40
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol (2009) 1.31
Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol (2003) 1.14
Supportive care for patients with Guillain-Barré syndrome. Arch Neurol (2005) 1.12
Muscle channelopathies: the nondystrophic myotonias and periodic paralyses. Continuum (Minneap Minn) (2013) 1.10
Guillain-Barré syndrome and variants. Neurol Clin (2013) 1.06
Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve (2011) 1.05
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve (2010) 1.05
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Muscle Nerve (2013) 1.03
cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies. Med Sci Monit (2004) 1.00
Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin (2013) 0.99
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis Rheumatol (2014) 0.97
Inclusion body myositis. Curr Neurol Neurosci Rep (2013) 0.95
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.94
An interactive voice response diary for patients with non-dystrophic myotonia. Muscle Nerve (2011) 0.92
Idiopathic inflammatory myopathies. Semin Neurol (2012) 0.92
Sporadic inclusion body myositis: new insights and potential therapy. Curr Opin Neurol (2014) 0.92
Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. Amyotroph Lateral Scler (2008) 0.88
Inclusion body myositis. Semin Neurol (2012) 0.87
Cryptogenic sensory polyneuropathy. Neurol Clin (2013) 0.87
Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromuscul Dis (2005) 0.87
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst (2010) 0.86
Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve (2009) 0.86
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes. Brain (2013) 0.86
Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. J Clin Neuromuscul Dis (2011) 0.85
Facial onset sensorimotor neuronopathy syndrome: a case series. J Clin Neuromuscul Dis (2012) 0.85
Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum (2003) 0.85
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve (2002) 0.84
Late-onset distal muscular dystrophy affecting the posterior calves. Muscle Nerve (2003) 0.83
Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol (2013) 0.83
Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve (2008) 0.83
Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29. J Neuropathol Exp Neurol (2011) 0.82
Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centers. J Clin Neuromuscul Dis (2013) 0.80
Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin (2013) 0.80
Idiopathic inflammatory myopathies. Front Neurol Neurosci (2009) 0.79
Management of myasthenia gravis. Semin Neurol (2004) 0.78
Guillain-barré syndrome. Curr Treat Options Neurol (2013) 0.78
A quantitative measure of handgrip myotonia in non-dystrophic myotonia. Muscle Nerve (2012) 0.78
Nutritional neuropathies. Neurol Clin (2013) 0.77
A review: the use of rituximab in neuromuscular diseases. J Clin Neuromuscul Dis (2010) 0.77
Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. Int J Neurosci (2011) 0.77
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. Neurology (2003) 0.76
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis. Neurotherapeutics (2015) 0.76
Acquired immune demyelinating neuropathies. Continuum (Minneap Minn) (2014) 0.76
Phase II trial of methotrexate in myasthenia gravis. Ann N Y Acad Sci (2012) 0.75
Expanding the evidence base for therapeutics in myasthenia gravis. Ann Neurol (2010) 0.75
A pattern recognition approach to myopathy. Continuum (Minneap Minn) (2013) 0.75
Less is More in Diabetic Neuropathy Diagnosis: Comparison of Quantitative Sudomotor Axon Reflex and Skin Biopsy. J Clin Neuromuscul Dis (2017) 0.75
Peripheral neuropathies. Preface. Neurol Clin (2013) 0.75
Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial. Phys Ther (2016) 0.75
Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Rep (2003) 0.75
Treatment of painful peripheral neuropathy. J Clin Neuromuscul Dis (2002) 0.75